EFDA current fee schedule, reviewed for 2026, in ETB.
5 fee lines100% exact amountscurrency ETBFX rates 2026-09-17reviewed 2026-09-16
| Fee line | Official amount | USD equivalent | Frequency | Provenance |
|---|---|---|---|---|
| New application screening Table 6 item 1. Payable before submitting the dossier or in parallel with the application submission. | ETB 350 | $2.16 | Per application | Verified |
| New application evaluation Table 6 item 2. Payable before submitting the dossier or in parallel with the application submission. | ETB 1300 | $8.03 | Per application | Verified |
| Renewal application evaluation Table 6 item 4. | ETB 870 | $5.37 | Per renewal application | Verified |
| Major variation application evaluation Table 6 item 5. EFDA administers post-approval changes under EFDA/GDL/098. | ETB 870 | $5.37 | Per variation application | Verified |
| Minor variation application evaluation Table 6 item 6. | ETB 650 | $4.01 | Per variation application | Verified |
- Table 6 of EFDA/GDL/046 reproduces the rates and states they are payable 'as per the Rate of Service Fees issued by Council of Minister Regulation No. 370/2015'.
- The tariff is flat across risk classes: screening and evaluation cost the same for a Class I and a Class IV device or for a Class A and a Class D IVD, so the low-risk and high-risk bands carry the same published total of 350 + 1300 birr.
- Two rows of Table 6 are denominated in US dollars - laboratory test at 200 US dollars and agency agreement at 50 US dollars - and are excluded here rather than converted, because this record publishes the birr tariff only.
- EFDA/GDL/046 Version 005 was approved on 05.06.2026 and its effective date is recorded in the document history as 25.06.2026.
Keep researching this market
More Ethiopia medical device resources
Continue with this market
Exact amounts verified against the EFDA fee schedule Β· full review 2026-09-16 Β· row IDs are stable β cite as government-fees:ethiopia:new-application-screening